{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T21:31:21Z","timestamp":1772659881880,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.berh.2010.03.001","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T08:38:42Z","timestamp":1282466322000},"page":"489-496","source":"Crossref","is-referenced-by-count":29,"title":["Novel targets in bone and cartilage"],"prefix":"10.1016","volume":"24","author":[{"given":"Christian","family":"Beyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.berh.2010.03.001_bib1","doi-asserted-by":"crossref","first-page":"iii42","DOI":"10.1136\/ard.2007.078972","article-title":"Joint remodelling in inflammatory disease","volume":"66","author":"Schett","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"10.1016\/j.berh.2010.03.001_bib2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","article-title":"Osteoclasts are essential for TNF-alpha-mediated joint destruction","volume":"110","author":"Redlich","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"issue":"6937","key":"10.1016\/j.berh.2010.03.001_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.berh.2010.03.001_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/ar2592","article-title":"Cartilage homeostasis in health and rheumatic diseases","volume":"11","author":"Goldring","year":"2009","journal-title":"Arthritis Research & Therapy"},{"issue":"12","key":"10.1016\/j.berh.2010.03.001_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.berh.2010.03.001_bib6","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.4049\/jimmunol.170.5.2655","article-title":"IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand\/osteoprotegerin balance","volume":"170","author":"Lubberts","year":"2003","journal-title":"Journal of Immunology"},{"issue":"12","key":"10.1016\/j.berh.2010.03.001_bib7","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"The Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.berh.2010.03.001_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nature Reviews. Immunology"},{"issue":"4","key":"10.1016\/j.berh.2010.03.001_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nature Reviews. Immunology"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2010.03.001_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/138161207780162962","article-title":"Emerging roles of cysteine cathepsins in disease and their potential as drug targets","volume":"13","author":"Vasiljeva","year":"2007","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.berh.2010.03.001_bib13","series-title":"Biological therapies in rheumatology","year":"2002"},{"issue":"6717","key":"10.1016\/j.berh.2010.03.001_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.berh.2010.03.001_bib17","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)64417-3","article-title":"Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis","volume":"161","author":"Romas","year":"2002","journal-title":"The American Journal of Pathology"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9440(10)63144-6","article-title":"Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis","volume":"164","author":"Redlich","year":"2004","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"10.1016\/j.berh.2010.03.001_bib19","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.21021","article-title":"Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models","volume":"52","author":"Schett","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"6759","key":"10.1016\/j.berh.2010.03.001_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.berh.2010.03.001_bib21","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-002-8530-7","article-title":"Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis","volume":"59","author":"Bolon","year":"2002","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"9","key":"10.1016\/j.berh.2010.03.001_bib22","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/art.24767","article-title":"Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis","volume":"60","author":"Schett","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2010.03.001_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0736-0266(03)00011-1","article-title":"Effects of receptor activator of NFkappaB (RANK) signalling blockade on fracture healing","volume":"21","author":"Flick","year":"2003","journal-title":"Journal of Orthopaedic Research"},{"issue":"6","key":"10.1016\/j.berh.2010.03.001_bib24","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar2879","article-title":"RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies","volume":"11","author":"Stolina","year":"2009","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"10.1016\/j.berh.2010.03.001_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncprheum0036","article-title":"Mechanisms of disease: the link between RANKL and arthritic bone disease","volume":"1","author":"Schett","year":"2005","journal-title":"Nature Clinical Practice. Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","article-title":"The effect of a single dose of osteoprotegerin in postmenopausal women","volume":"16","author":"Bekker","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3 Suppl.","key":"10.1016\/j.berh.2010.03.001_bib27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.berh.2010.03.001_bib28","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1359\/jbmr.2005.20.12.2274","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004","volume":"20","author":"Bekker","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"issue":"8","key":"10.1016\/j.berh.2010.03.001_bib29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.berh.2010.03.001_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.1780390307","article-title":"Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial","volume":"39","author":"Eggelmeijer","year":"1996","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2010.03.001_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/03009749409103063","article-title":"Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis","volume":"23","author":"Maccagno","year":"1994","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2010.03.001_bib32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/ard.48.5.396","article-title":"Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis","volume":"48","author":"Ralston","year":"1989","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1016\/j.berh.2010.03.001_bib33","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"9","key":"10.1016\/j.berh.2010.03.001_bib34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ng1614","article-title":"Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation","volume":"37","author":"Li","year":"2005","journal-title":"Nature Genetics"},{"issue":"20","key":"10.1016\/j.berh.2010.03.001_bib35","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signalling","volume":"280","author":"Li","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.berh.2010.03.001_bib37","unstructured":"Ettenberg S, Cong F, Shulok J, et\u00a0al. BHQ880, a novel anti-DKK1 neutralizing antibody, inhibits tumor-induced osteolytic bone disease. American Association for Cancer Research Annual Meeting, April 12\u201316, 2008, San Diego, California."},{"issue":"11","key":"10.1016\/j.berh.2010.03.001_bib38","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","article-title":"Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo","volume":"4","author":"Choi","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.berh.2010.03.001_bib39","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1074\/jbc.M400524200","article-title":"Sclerostin inhibition of Wnt-3a-induced C3H10T1\/2 cell differentiation is indirect and mediated by bone morphogenetic proteins","volume":"280","author":"Winkler","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"29","key":"10.1016\/j.berh.2010.03.001_bib40","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signalling inhibitor","volume":"280","author":"Semenov","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.berh.2010.03.001_bib41","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Research"},{"issue":"23","key":"10.1016\/j.berh.2010.03.001_bib42","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"The EMBO Journal"},{"issue":"6","key":"10.1016\/j.berh.2010.03.001_bib43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"10.1016\/j.berh.2010.03.001_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"American Journal of Human Genetics"},{"issue":"11","key":"10.1016\/j.berh.2010.03.001_bib45","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","article-title":"Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis","volume":"60","author":"Appel","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"13","key":"10.1016\/j.berh.2010.03.001_bib46","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"The FASEB Journal"},{"issue":"5","key":"10.1016\/j.berh.2010.03.001_bib47","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jcb.20466","article-title":"Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta","volume":"95","author":"Dong","year":"2005","journal-title":"Journal of Cellular Biochemistry"},{"issue":"Pt 9","key":"10.1016\/j.berh.2010.03.001_bib48","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1242\/jcs.020362","article-title":"Inhibition of beta-catenin signalling causes defects in postnatal cartilage development","volume":"121","author":"Chen","year":"2008","journal-title":"Journal of Cell Science"},{"issue":"3","key":"10.1016\/j.berh.2010.03.001_bib49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/labinvest.3700747","article-title":"Wnt\/beta-catenin signalling stimulates matrix catabolic genes and activity in articular chondrocytes: its possible role in joint degeneration","volume":"88","author":"Yuasa","year":"2008","journal-title":"Laboratory Investigation"},{"issue":"12","key":"10.1016\/j.berh.2010.03.001_bib50","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1002\/art.23137","article-title":"Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice","volume":"56","author":"Lories","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"7","key":"10.1016\/j.berh.2010.03.001_bib51","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1371\/journal.pmed.0040249","article-title":"Beta-catenin signalling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing","volume":"4","author":"Chen","year":"2007","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.berh.2010.03.001_bib52","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.23444","article-title":"Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signalling after injury and in osteoarthritis","volume":"58","author":"Dell\u2019accio","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"12","key":"10.1016\/j.berh.2010.03.001_bib53","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1359\/jbmr.070724","article-title":"Enhanced chondrogenesis and Wnt signalling in PTH-treated fractures","volume":"22","author":"Kakar","year":"2007","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.berh.2010.03.001_bib54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.clpt.6100450","article-title":"Cathepsin K inhibitors: a novel target for osteoporosis therapy","volume":"83","author":"Stoch","year":"2008","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib55","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/art.23224","article-title":"Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice","volume":"58","author":"Schurigt","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"5863","key":"10.1016\/j.berh.2010.03.001_bib56","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1126\/science.1150110","article-title":"Cathepsin K-dependent toll-like receptor 9 signalling revealed in experimental arthritis","volume":"319","author":"Asagiri","year":"2008","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.berh.2010.03.001_bib57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/BOR.0b013e32832cbc2a","article-title":"Future therapeutic targets in osteoporosis","volume":"21","author":"Deal","year":"2009","journal-title":"Current Opinion in Rheumatology"},{"issue":"Suppl. 1","key":"10.1016\/j.berh.2010.03.001_bib58","article-title":"Effect of one year treatment with the cathepsin-K inhibitor, balicatib, on bone mineral density (BMD) in postmenopausal women with osteopenia\/osteoporosis","volume":"21","author":"Adami","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"issue":"Suppl. 1","key":"10.1016\/j.berh.2010.03.001_bib59","article-title":"Effect of three month treatment with the cathepsin-K inhibitor, balicatib, on biochemical markers of bone turnover in postmenopausal women: evidence for uncoupling of bone resorption and bone formation","volume":"21","author":"Papanastasiou","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/clpt.2009.60","article-title":"Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies","volume":"86","author":"Stoch","year":"2009","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"9","key":"10.1016\/j.berh.2010.03.001_bib61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.molmed.2009.07.002","article-title":"Mechanisms of bone repair and regeneration","volume":"15","author":"Deschaseaux","year":"2009","journal-title":"Trends in Molecular Medicine"},{"issue":"5","key":"10.1016\/j.berh.2010.03.001_bib62","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.devcel.2008.03.007","article-title":"Patched1 haploinsufficiency increases adult bone mass and modulates Gli3 repressor activity","volume":"14","author":"Ohba","year":"2008","journal-title":"Developmental Cell"},{"issue":"5","key":"10.1016\/j.berh.2010.03.001_bib63","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.devcel.2008.02.003","article-title":"Hedgehog signalling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression","volume":"14","author":"Mak","year":"2008","journal-title":"Developmental Cell"},{"issue":"12","key":"10.1016\/j.berh.2010.03.001_bib64","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nm.2055","article-title":"Modulating hedgehog signalling can attenuate the severity of osteoarthritis","volume":"15","author":"Lin","year":"2009","journal-title":"Nature Medicine"},{"issue":"5678","key":"10.1016\/j.berh.2010.03.001_bib65","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1126\/science.1098020","article-title":"The Hedgehog response network: sensors, switches, and routers","volume":"304","author":"Lum","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.berh.2010.03.001_bib66","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2741\/1850","article-title":"Repeated mechanical loading enhances the expression of Indian hedgehog in condylar cartilage","volume":"11","author":"Ng","year":"2006","journal-title":"Frontiers in Bioscience"},{"issue":"7","key":"10.1016\/j.berh.2010.03.001_bib67","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ncprheum0534","article-title":"Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis\u2013structure, chaos and senescence","volume":"3","author":"Aigner","year":"2007","journal-title":"Nature Clinical Practice. Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2010.03.001_bib68","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","article-title":"FGFs, heparan sulfate and FGFRs: complex interactions essential for development","volume":"22","author":"Ornitz","year":"2000","journal-title":"Bioessays"},{"issue":"7","key":"10.1016\/j.berh.2010.03.001_bib69","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.965602","article-title":"Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18","volume":"16","author":"Liu","year":"2002","journal-title":"Genes & Development"},{"issue":"16","key":"10.1016\/j.berh.2010.03.001_bib70","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1242\/dev.129.16.3783","article-title":"The IIIc alternative of Fgfr2 is a positive regulator of bone formation","volume":"129","author":"Eswarakumar","year":"2002","journal-title":"Development"},{"issue":"12","key":"10.1016\/j.berh.2010.03.001_bib71","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","article-title":"FGF signalling pathways in endochondral and intramembranous bone development and human genetic disease","volume":"16","author":"Ornitz","year":"2002","journal-title":"Genes & Development"},{"issue":"4","key":"10.1016\/j.berh.2010.03.001_bib72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/joca.2002.0514","article-title":"Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors","volume":"10","author":"Ellsworth","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"issue":"21","key":"10.1016\/j.berh.2010.03.001_bib73","doi-asserted-by":"crossref","first-page":"20509","DOI":"10.1074\/jbc.M410148200","article-title":"Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis","volume":"280","author":"Davidson","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.berh.2010.03.001_bib74","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1101\/gad.965702","article-title":"FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis","volume":"16","author":"Ohbayashi","year":"2002","journal-title":"Genes & Development"},{"issue":"1","key":"10.1016\/j.berh.2010.03.001_bib75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2184.2009.00655.x","article-title":"Involvement of fibroblast growth factor 18 in dedifferentiation of cultured human chondrocytes","volume":"43","author":"Yamaoka","year":"2010","journal-title":"Cell Proliferation"},{"issue":"7","key":"10.1016\/j.berh.2010.03.001_bib76","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.joca.2005.03.003","article-title":"Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis","volume":"13","author":"Moore","year":"2005","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694210000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694210000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T23:31:41Z","timestamp":1636241501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694210000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1521694210000288"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2010.03.001","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}